 Shares of Cidara Therapeutics Inc NASDAQ:CDTX have been assigned an average rating of Buy from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 1 year target price among ... 